112 related articles for article (PubMed ID: 33870932)
21. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
22. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
[TBL] [Abstract][Full Text] [Related]
23. Dynamic spatiotemporal expression of LIM genes and cofactors in the embryonic and postnatal cerebral cortex.
Bulchand S; Subramanian L; Tole S
Dev Dyn; 2003 Mar; 226(3):460-9. PubMed ID: 12619132
[TBL] [Abstract][Full Text] [Related]
24. LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer.
Du L; Zhao Z; Suraokar M; Shelton SS; Ma X; Hsiao TH; Minna JD; Wistuba I; Pertsemlidis A
Oncotarget; 2018 Jul; 9(51):29601-29618. PubMed ID: 30038707
[TBL] [Abstract][Full Text] [Related]
25. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.
Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD
Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382
[TBL] [Abstract][Full Text] [Related]
27. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
28. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
[TBL] [Abstract][Full Text] [Related]
29. LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway.
Gao L; Wu J; Wang H; Yang Y; Zheng Z; Ni B; Wang X; Peng Y; Li Y
Front Oncol; 2022; 12():770299. PubMed ID: 35280742
[TBL] [Abstract][Full Text] [Related]
30. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
31. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
[TBL] [Abstract][Full Text] [Related]
32. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
[TBL] [Abstract][Full Text] [Related]
33. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
[TBL] [Abstract][Full Text] [Related]
34. The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11).
Valge-Archer V; Forster A; Rabbitts TH
Oncogene; 1998 Dec; 17(24):3199-202. PubMed ID: 9872335
[TBL] [Abstract][Full Text] [Related]
35. Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: differential regulation by seizure activity.
Hinks GL; Shah B; French SJ; Campos LS; Staley K; Hughes J; Sofroniew MV
J Neurosci; 1997 Jul; 17(14):5549-59. PubMed ID: 9204936
[TBL] [Abstract][Full Text] [Related]
36. Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).
Beuten J; Gelfond JA; Piwkham D; Pollock BH; Winick NJ; Collier AB; Tomlinson GE
Carcinogenesis; 2011 Sep; 32(9):1349-53. PubMed ID: 21602560
[TBL] [Abstract][Full Text] [Related]
37. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors.
Ostendorff HP; Peirano RI; Peters MA; Schlüter A; Bossenz M; Scheffner M; Bach I
Nature; 2002 Mar; 416(6876):99-103. PubMed ID: 11882901
[TBL] [Abstract][Full Text] [Related]
39. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
40. A single ancestral gene of the human LIM domain oncogene family LMO in Drosophila: characterization of the Drosophila Dlmo gene.
Zhu TH; Bodem J; Keppel E; Paro R; Royer-Pokora B
Oncogene; 1995 Oct; 11(7):1283-90. PubMed ID: 7478548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
